Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 7

1.

High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen.

Humblet V, Lapidus R, Williams LR, Tsukamoto T, Rojas C, Majer P, Hin B, Ohnishi S, De Grand AM, Zaheer A, Renze JT, Nakayama A, Slusher BS, Frangioni JV.

Mol Imaging. 2005 Oct-Dec;4(4):448-62.

PMID:
16285907
2.

Lighting up tumors with receptor-specific optical molecular probes.

Achilefu S.

Technol Cancer Res Treat. 2004 Aug;3(4):393-409. Review.

PMID:
15270591
3.

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.

Ghosh A, Heston WD.

J Cell Biochem. 2004 Feb 15;91(3):528-39. Review.

PMID:
14755683
4.

Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy.

Nakayama A, del Monte F, Hajjar RJ, Frangioni JV.

Mol Imaging. 2002 Oct;1(4):365-77.

PMID:
12940233
5.

Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging.

Ntziachristos V, Bremer C, Weissleder R.

Eur Radiol. 2003 Jan;13(1):195-208. Epub 2002 Jul 19. Review.

PMID:
12541130
6.

Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer.

Feneley MR, Jan H, Granowska M, Mather SJ, Ellison D, Glass J, Coptcoat M, Kirby RS, Ogden C, Oliver RT, Badenoch DF, Chinegwundoh FI, Nargund VH, Paris AM, Britton KE.

Prostate Cancer Prostatic Dis. 2000 Jul;3(1):47-52.

7.

Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).

Luthi-Carter R, Barczak AK, Speno H, Coyle JT.

J Pharmacol Exp Ther. 1998 Aug;286(2):1020-5.

Supplemental Content

Support Center